GC Biopharma wins approval for quadrivalent flu vaccine in Egypt

This is the first time GC Flu Quadrivalent has received approval in Africa

GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
Ji-Hyun Lee 1
2023-07-19 15:30:10 bluesky@hankyung.com
Bio & Pharma

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egyptian health regulatory authorities.

This is the first approval for this product in the African continent. According to the company, Egypt is one of the countries with the largest pharmaceutical markets in Africa.

Based on this approval, the company plans to expand its export markets beyond Southeast Asia and Latin America to Africa and the Middle East, and accelerate its entry into specific private-sector markets in each country.

"Based on our excellent vaccine technology and manufacturing capabilities accumulated over half a century, we will continue to increase our global market share," said Huh Eun-chul, CEO of GC Biopharma.

Write to Ji-Hyun Lee at bluesky@hankyung.com

GC Biopharma inks $90mn deal for blood products in Brazil

GC Biopharma inks $90mn deal for blood products in Brazil

Huh Eun-chul, CEO of GC Biopharma (left) and Marcelo Rodolfo Hahn, CEO of Blau Farmacêutica South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutical firm, for its IVIG-SN 5% blood product. Th

GC Biopharma wins contract to build blood products plant in Indonesia

GC Biopharma wins contract to build blood products plant in Indonesia

GC Biopharma's headquarters GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Health for the construction and technology transfer of a blood products plant.The Indonesian government has been undertaking

GC Biopharma wins $44 mn flu vaccine order from WHO agency

GC Biopharma wins $44 mn flu vaccine order from WHO agency

South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a drug tender offered by the Pan American Health Organization (PAHO), an arm of the World Health Organization (WHO).Accordingly, GC's flu vaccine wil

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The drug maker said it has exercised an option contract with Acuitas Therapeutics, a Canadian pharma that specializes in lipid nano particle (LNP) deliv

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter the World Health Organization (WHO) procurement market with Barycela following its export hit Suduvax. This breakthrough is expected to heat up glob

(* comment hide *}